Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

410 Medical develops innovative resuscitation technologies for emergency and critical care.

view more →

Aer Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class inhaled therapies that target mucus obstruction in chronic lung diseases.

view more →

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.

view more →

AtaCor Medical is developing next-generation cardiac rhythm management systems

view more →

Providing in-home primary care for seniors with complex conditions, especially those with dementia

view more →

Atsena Therapeutics is a clinical-stage gene therapy company focused on reversing or preventing blindness from inherited retinal diseases

view more →

Avivomed is a Minneapolis-based medical device company developing next-generation neuromodulation therapies

view more →

Axonis Therapeutics is a clinical-stage biotechnology company developing first-in-class small molecule therapies that target KCC2

view more →

Ed-tech platform that pairs high achieving, under-resourced students with mentors to guide them to successful career outcomes

view more →

Their clinical research software accelerates timelines by automating multiple high impact processes.

view more →

Boomerang Medical is a bioelectronic medicine company developing neuromodulation technologies to treat autoimmune diseases

view more →

Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies

view more →

Carallel is a digital health company that provides personalized guidance, expert support, and technology tools

view more →

Contego Medical develops integrated medical devices for revascularization procedures

view more →

CREATE Medicines is a clinical-stage biotechnology company pioneering a new class of in vivo immune programming therapies

view more →

Elligo Health Research is a healthcare-enabling research organization that integrates clinical trials directly into routine patient care

view more →

Endogenex is a clinical-stage medical technology company developing a novel, minimally invasive endoscopic procedure for people with type 2 diabetes.

view more →

Entegrion develops point-of-care hemostasis solutions centered on its Viscoelastic Coagulation Monitor (VCM)

view more →

GeneCentric’s mission is to address the urgent unmet need in precision oncology for better biomarkers and to bring these biomarkers to liquid biopsies.

view more →

GoCheck Kids provides a smartphone-based pediatric vision and hearing screening platform

view more →

Gozio Health is a digital health company that provides a customizable, mobile engagement platform for health systems

view more →

Huma.AI is a life sciences–focused generative AI company that provides a secure knowledge platform

view more →

MMvention Therapeutix, Inc. is an early-stage biotechnology company focused on discovering and developing novel oral small-molecule therapeutics

view more →

iVEAcare is developing next-generation neuromodulation therapies using advanced implantable devices and software

view more →

Mercy BioAnalytics is a biotechnology company developing blood-based tests for the early detection of cancer

view more →

Operator of a biopharmaceutical agency intended to offer drugs for the treatment of diabetes and other metabolic disorders.

view more →

Perfuse Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class therapies to improve retinal blood flow and treat ischemia-driven eye diseases.

view more →

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

view more →

RapidPulse is a medical device company developing an innovative, minimally invasive vascular system for treating acute ischemic stroke.

view more →

Ribometrix is a biotechnology company pioneering a new class of small-molecule therapeutics that directly target the three-dimensional structures of RNA to modulate disease biology.

view more →

Rx Redefined is a healthcare technology company that provides a compliance-focused platform

view more →

SafeRide Health is a healthcare technology and services company that improves access to care by coordinating non-emergency medical transportation for vulnerable populations.

view more →

Sensorium Therapeutics is a clinical-stage biotechnology company developing next-generation brain and mental health medicines.

view more →

Synaptrix is developing a first-in-kind, drug-free neuromodulation therapy for post-operative pain

view more →

Ten63 Therapeutics is a computational drug discovery company leveraging its proprietary AI- and physics-based platform to design novel therapeutics

view more →

Trefoil Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to restore vision for people with corneal diseases.

view more →

Tune Therapeutics is a biotechnology innovator advancing a new class of epi-therapeutic medicines

view more →

Vircho is a healthcare technology company that connects healthcare organizations with community-based social services

view more →

Wesper is a digital health company developing an FDA-cleared, at-home sleep testing platform that delivers clinical-grade diagnostics for sleep disorders

view more →

Wildflower Health is a digital health company focused on women’s and maternal health

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910